Delisted
Stopped trading. Last price we have: $21.64 on Feb 1, 2026. Fund positions aren't valued until we confirm what happened.

AVADEL PHARMACEUTICALS
AVDLHealthcare
AVDL (AVADEL PHARMACEUTICALS) is held by 0 institutional investors as of Q1 2026.
No verdict yet — fewer than 2 funds hold AVDL.
Top Holders
Fund ownership
Fund holdings as of
Funds holding0
Value of reported holdings$0
Funds buying / selling
Not available
Checking access…
Showing 1-20 of 113
1 / 6
| Insider | Trade | Traded |
|---|---|---|
| Weiss Asset Management LP | Sell $233.4M | |
| Thornton Peter J. | Vest 11K sh | |
| Palczuk Linda | Vest 11K sh | |
| Ende Eric J | Vest 11K sh | |
| Amin Naseem | Vest 11K sh | |
| McCamish Mark Anthony | Vest 11K sh | |
| Glass Geoffrey Michael | Vest 11K sh |
Loading Congress trades…
| Filer | Stake | Filed |
|---|---|---|
| Two Seas Capital LP | 0.0% | |
| JANUS HENDERSON GROUP PLC | 1.9% | |
| BRANDES INVESTMENT PARTNERS, LP | 0.2% | |
| The Vanguard Group | 5.7% | |
| BlackRock, Inc. | 7.0% |
Continue exploring
Other Healthcare stocks held by institutions
456 holders · $264.6B
455 holders · $846.2B
442 holders · $208.3B
438 holders · $117B
437 holders · $430.7B
432 holders · $256.6B
425 holders · $314.1B
425 holders · $109.3B
418 holders · $123.6B
412 holders · $151.2B
Questions investors ask about AVDL
Who owns AVDL?
0 institutional investors held AVDL on March 31, 2026, according to their 13F filings.
How many hedge funds hold AVDL?
0 institutional investors reported AVDL in their 13F filings for the quarter ended March 31, 2026.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer